Ledger.Open graph →
SEC Form D · filed January 23, 2015

Aspyrian Therapeutics, Inc

Offering
$8.5M
Sold
$8.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Miguel Garcia-Guzman · San Diego, CAExec · DirectorSamuel Ulloa · San Francisco, CAExec · DirectorScott Salka · San Diego, CAExec · DirectorDaniel Carroll · San Francisco, CAExec · DirectorScott Salka · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗